Share Price and Basic Stock Data
Last Updated: December 10, 2025, 9:38 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Maha Rashtra Apex Corporation Ltd operates in the finance and investment sector, a domain that has seen varying performance amid economic fluctuations. As of the latest reports, the company’s stock price stood at ₹74.3 with a market capitalization of ₹105 Cr. Revenue generation has been erratic, with reported sales fluctuating significantly over the last several quarters. In fact, sales figures were as low as ₹0 and peaked at ₹7 in the March 2024 quarter. Such volatility raises questions about the company’s operational reliability. The trailing twelve months (TTM) revenue is reported at ₹1, which is considerably low compared to its historical performance, suggesting a need for strategic realignment. Given the inconsistent sales, stakeholders may want to scrutinize the company’s operational model closely to understand the underlying causes of these trends.
Profitability and Efficiency Metrics
When it comes to profitability, Maha Rashtra Apex Corporation has displayed a mixed bag of results. The operating profit margin (OPM) has experienced dramatic swings, recording figures such as -840% in June 2025, indicating a severe operational inefficiency during certain periods. However, the company did report a remarkable turnaround in March 2024, achieving an OPM of 82%, showcasing its potential to generate profit under optimal conditions. The return on equity (ROE) is impressive at 71.2%, which suggests that the company has been effective in generating returns for its shareholders, despite the challenges in revenue generation. The interest coverage ratio is exceptionally high at 25,499.50x, reflecting a robust capacity to manage any interest obligations, which is a comforting sign for investors. Nevertheless, the erratic nature of its profitability metrics calls for cautious interpretation.
Balance Sheet Strength and Financial Ratios
The balance sheet of Maha Rashtra Apex Corporation reveals a strong position regarding borrowings, as the company reported zero debt at ₹0.00 Cr. This is a significant strength, especially in a capital-intensive sector, as it provides the company with considerable financial flexibility. Furthermore, the reserves have shown a consistent upward trend, reaching ₹445.09 Cr, which is a positive indicator of financial health. However, the price-to-book value ratio is notably low at 0.31x, suggesting that the stock may be undervalued in relation to its book value. While this can present a buying opportunity, it also raises questions about market perception and investor confidence. Additionally, the current ratio of 0.27x indicates a potential liquidity concern, which should be monitored closely as it may affect the company’s short-term obligations.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Maha Rashtra Apex Corporation reveals that promoters hold a substantial 62.54% stake, which suggests a strong commitment from the management. However, the presence of institutional investors appears minimal, with foreign institutional investors (FIIs) absent and domestic institutional investors (DIIs) holding just 0.01%. This lack of institutional backing may raise concerns about the stock’s attractiveness to larger investors. The public shareholding stands at 37.47%, with a total of 15,333 shareholders reported, indicating a relatively broad base of retail investors. While promoter confidence is a positive sign, the low institutional interest could be a red flag for potential investors, signaling a need for the company to enhance its visibility and market appeal.
Outlook, Risks, and Final Insight
The outlook for Maha Rashtra Apex Corporation appears to hinge on its ability to stabilize its revenue streams and enhance operational efficiency. The erratic sales figures and fluctuating profitability metrics suggest that the company must undertake a thorough review of its business strategy. Risks include potential liquidity issues, as indicated by the low current ratio, and the lack of institutional support, which may limit stock price appreciation. On the other hand, the company’s robust ROE and zero debt position provide a solid foundation for future growth. Investors should weigh these strengths against the risks and consider the company’s ability to execute a turnaround strategy effectively. As the market environment evolves, maintaining a close watch on operational performance and market sentiment will be crucial for any investment decision regarding Maha Rashtra Apex Corporation.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Maha Rashtra Apex Corporation Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 12.3 Cr. | 41.8 | 67.7/36.4 | 49.0 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,364 Cr. | 298 | 484/280 | 15.2 | 111 | 0.34 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 33.8 Cr. | 0.48 | 2.26/0.46 | 4.67 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 5.20 Cr. | 10.5 | 12.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 23.0 Cr. | 44.8 | 72.0/43.7 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,205.35 Cr | 1,383.00 | 80.78 | 3,844.37 | 0.36% | 21.70% | 14.20% | 7.22 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 7 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 2 | 0 | 1 | 3 | 1 | 1 | 91 | 1 | 1 | 9 | 13 | 0 | 0 |
| Operating Profit | -2 | -0 | 0 | -2 | -0 | -0 | -90 | 6 | -0 | -9 | -13 | -0 | -0 |
| OPM % | -340% | -225% | 4% | -426% | -94% | -19% | -14,314% | 82% | -92% | -1,833% | -25,920% | -50% | -840% |
| Other Income | 3 | 1 | 0 | 3 | 1 | 3 | 0 | 414 | 1 | 1 | 6 | 27 | 24 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 2 | 1 | 0 | 0 | 0 | 3 | -90 | 419 | 0 | -8 | -7 | 26 | 24 |
| Tax % | 0% | 0% | 2% | -225% | 0% | 16% | 0% | 0% | 0% | -0% | 2% | 15% | 0% |
| Net Profit | 2 | 1 | 0 | 0 | 0 | 2 | -90 | 418 | 0 | -8 | -7 | 22 | 24 |
| EPS in Rs | 1.14 | 0.73 | 0.28 | 0.18 | 0.27 | 1.71 | -63.39 | 295.68 | 0.20 | -5.63 | -4.81 | 15.83 | 16.86 |
Last Updated: August 20, 2025, 7:30 am
Below is a detailed analysis of the quarterly data for Maha Rashtra Apex Corporation Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For OPM %, as of Jun 2025, the value is -840.00%. The value appears to be declining and may need further review. It has decreased from -50.00% (Mar 2025) to -840.00%, marking a decrease of 790.00%.
- For Other Income, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 2.00 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 15.00% (Mar 2025) to 0.00%, marking a decrease of 15.00%.
- For Net Profit, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 2.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 16.86. The value appears strong and on an upward trend. It has increased from 15.83 (Mar 2025) to 16.86, marking an increase of 1.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:55 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2 | 2 | 1 | 9 | 10 | 9 | 5 | 8 | 8 | 9 | 9 | 8 | 1 |
| Expenses | 1 | 5 | 3 | 4 | 5 | 5 | 7 | 3 | 9 | 52 | 51 | 3 | 23 |
| Operating Profit | 0 | -3 | -1 | 5 | 5 | 4 | -1 | 5 | -1 | -43 | -41 | 5 | -22 |
| OPM % | 15% | -152% | -97% | 53% | 51% | 45% | -20% | 62% | -8% | -500% | -438% | 63% | -2,538% |
| Other Income | 1 | 6 | 3 | 3 | 1 | 7 | 15 | 27 | 3 | 2 | 3 | 335 | 58 |
| Interest | 3 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -2 | 0 | -0 | 6 | 5 | 10 | 14 | 32 | 2 | -42 | -39 | 340 | 36 |
| Tax % | 2% | 58% | 60% | 1% | 17% | -0% | 0% | -5% | 30% | 0% | 4% | 1% | |
| Net Profit | -2 | 0 | -0 | 29 | 54 | 10 | 14 | 34 | 1 | -42 | -40 | 336 | 31 |
| EPS in Rs | -1.26 | 0.05 | -0.06 | 20.54 | 38.13 | 7.08 | 9.68 | 23.83 | 0.95 | -29.60 | -28.59 | 237.26 | 22.25 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 86.21% | -81.48% | 40.00% | 142.86% | -97.06% | -4300.00% | 4.76% | 940.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -13.79% | -167.69% | 121.48% | 102.86% | -239.92% | -4202.94% | 4304.76% | 935.24% |
Maha Rashtra Apex Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -24% |
| 3 Years: | -44% |
| TTM: | -90% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | -4% |
| 3 Years: | 167% |
| TTM: | -93% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 29% |
| 3 Years: | 35% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 10:10 am
Balance Sheet
Last Updated: December 4, 2025, 1:36 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14.11 | 14.11 | 14.11 | 14.11 | 14.12 | 14.12 | 14.12 | 14.12 | 14.12 | 14.12 | 14.12 | 14.12 | 14.12 |
| Reserves | -86.66 | -86.63 | -86.75 | 22.98 | 76.83 | 87.29 | 101.01 | 134.77 | 136.27 | 98.83 | 431.82 | 451.72 | 445.09 |
| Borrowings | 3.53 | 9.52 | 0.48 | 5.94 | 5.62 | 5.93 | 5.93 | 0.32 | 0.32 | 0.39 | 0.50 | 0.32 | 0.00 |
| Other Liabilities | 144.36 | 142.98 | 132.02 | 109.01 | 104.57 | 103.19 | 107.12 | 111.39 | 109.88 | 95.68 | 87.36 | 76.96 | 76.99 |
| Total Liabilities | 75.34 | 79.98 | 59.86 | 152.04 | 201.14 | 210.53 | 228.18 | 260.60 | 260.59 | 209.02 | 533.80 | 543.12 | 536.20 |
| Fixed Assets | 6.71 | 6.92 | 6.86 | 3.03 | 3.01 | 2.90 | 2.95 | 2.92 | 2.88 | 2.85 | 2.77 | 3.63 | 3.62 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 19.03 | 18.81 | 18.90 | 139.19 | 190.46 | 196.09 | 209.31 | 238.20 | 235.59 | 187.92 | 504.34 | 512.61 | 504.74 |
| Other Assets | 49.60 | 54.25 | 34.10 | 9.82 | 7.67 | 11.54 | 15.92 | 19.48 | 22.12 | 18.25 | 26.69 | 26.88 | 27.84 |
| Total Assets | 75.34 | 79.98 | 59.86 | 152.04 | 201.14 | 210.53 | 228.18 | 260.60 | 260.59 | 209.02 | 533.80 | 543.12 | 536.20 |
Below is a detailed analysis of the balance sheet data for Maha Rashtra Apex Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 14.12 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.12 Cr..
- For Reserves, as of Sep 2025, the value is 445.09 Cr.. The value appears to be declining and may need further review. It has decreased from 451.72 Cr. (Mar 2025) to 445.09 Cr., marking a decrease of 6.63 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.32 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.32 Cr..
- For Other Liabilities, as of Sep 2025, the value is 76.99 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 76.96 Cr. (Mar 2025) to 76.99 Cr., marking an increase of 0.03 Cr..
- For Total Liabilities, as of Sep 2025, the value is 536.20 Cr.. The value appears to be improving (decreasing). It has decreased from 543.12 Cr. (Mar 2025) to 536.20 Cr., marking a decrease of 6.92 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3.62 Cr.. The value appears to be declining and may need further review. It has decreased from 3.63 Cr. (Mar 2025) to 3.62 Cr., marking a decrease of 0.01 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 504.74 Cr.. The value appears to be declining and may need further review. It has decreased from 512.61 Cr. (Mar 2025) to 504.74 Cr., marking a decrease of 7.87 Cr..
- For Other Assets, as of Sep 2025, the value is 27.84 Cr.. The value appears strong and on an upward trend. It has increased from 26.88 Cr. (Mar 2025) to 27.84 Cr., marking an increase of 0.96 Cr..
- For Total Assets, as of Sep 2025, the value is 536.20 Cr.. The value appears to be declining and may need further review. It has decreased from 543.12 Cr. (Mar 2025) to 536.20 Cr., marking a decrease of 6.92 Cr..
Notably, the Reserves (445.09 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -3.53 | -12.52 | -1.48 | -0.94 | -0.62 | -1.93 | -6.93 | 4.68 | -1.32 | -43.39 | -41.50 | 4.68 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 2,131 | 1,453 | 1,513 | 15 | 16 | 27 | 18 | 8 | 9 | 5 | 8 | 0 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 2,131 | 1,453 | 1,513 | 15 | 16 | 27 | 18 | 8 | 9 | 5 | 8 | 0 |
| Working Capital Days | -26,591 | -21,343 | -27,216 | -4,730 | -3,952 | -4,142 | -7,176 | -4,515 | -4,571 | -3,675 | -2,747 | -2,865 |
| ROCE % | 8% | 4% | 12% | 23% | -0% | -33% | -15% | 72% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 13.95 | 245.82 | -29.72 | 0.95 | 23.93 |
| Diluted EPS (Rs.) | 13.95 | 245.82 | -29.72 | 0.95 | 23.93 |
| Cash EPS (Rs.) | 8.51 | 5.53 | 3.67 | 3.65 | 5.83 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 329.96 | 326.43 | 80.01 | 106.53 | 105.47 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 329.96 | 326.43 | 80.01 | 106.53 | 105.47 |
| Revenue From Operations / Share (Rs.) | 0.96 | 6.17 | 1.51 | 2.76 | 2.17 |
| PBDIT / Share (Rs.) | 3.61 | 4.92 | 2.91 | 3.20 | 3.86 |
| PBIT / Share (Rs.) | 3.59 | 4.89 | 2.88 | 3.17 | 3.84 |
| PBT / Share (Rs.) | 11.43 | 6.57 | 3.73 | 4.04 | 4.69 |
| Net Profit / Share (Rs.) | 8.49 | 5.50 | 3.65 | 3.63 | 5.81 |
| NP After MI And SOA / Share (Rs.) | 237.80 | 245.37 | -29.66 | 0.95 | 23.88 |
| PBDIT Margin (%) | 374.74 | 79.63 | 192.90 | 116.10 | 177.81 |
| PBIT Margin (%) | 372.06 | 79.17 | 191.00 | 115.16 | 176.75 |
| PBT Margin (%) | 1185.26 | 106.48 | 247.00 | 146.51 | 215.83 |
| Net Profit Margin (%) | 880.65 | 89.09 | 241.67 | 131.50 | 267.43 |
| NP After MI And SOA Margin (%) | 24669.02 | 3975.34 | -1966.06 | 34.47 | 1099.83 |
| Return on Networth / Equity (%) | 72.06 | 75.16 | -37.07 | 0.89 | 22.64 |
| Return on Capital Employeed (%) | 1.08 | 1.49 | 3.59 | 2.98 | 3.63 |
| Return On Assets (%) | 61.81 | 63.13 | -20.03 | 0.51 | 12.93 |
| Asset Turnover Ratio (%) | 0.00 | 0.02 | 0.00 | 0.01 | 0.00 |
| Current Ratio (X) | 0.27 | 0.19 | 0.14 | 0.16 | 0.13 |
| Quick Ratio (X) | 0.27 | 0.19 | 0.14 | 0.16 | 0.13 |
| Interest Coverage Ratio (X) | 25499.50 | 475.29 | 1521.81 | 273.88 | 179.32 |
| Interest Coverage Ratio (Post Tax) (X) | 4589.50 | 368.69 | 1464.81 | 236.26 | 230.29 |
| Enterprise Value (Cr.) | 143.62 | 185.77 | 122.56 | 126.99 | 87.84 |
| EV / Net Operating Revenue (X) | 105.53 | 21.32 | 57.54 | 32.63 | 28.65 |
| EV / EBITDA (X) | 28.16 | 26.77 | 29.83 | 28.10 | 16.11 |
| MarketCap / Net Operating Revenue (X) | 107.89 | 21.39 | 59.02 | 33.89 | 30.32 |
| Price / BV (X) | 0.31 | 0.40 | 1.11 | 0.87 | 0.62 |
| Price / Net Operating Revenue (X) | 108.00 | 21.39 | 59.05 | 33.90 | 30.33 |
| EarningsYield | 2.29 | 1.86 | -0.33 | 0.01 | 0.36 |
After reviewing the key financial ratios for Maha Rashtra Apex Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 13.95. This value is within the healthy range. It has decreased from 245.82 (Mar 24) to 13.95, marking a decrease of 231.87.
- For Diluted EPS (Rs.), as of Mar 25, the value is 13.95. This value is within the healthy range. It has decreased from 245.82 (Mar 24) to 13.95, marking a decrease of 231.87.
- For Cash EPS (Rs.), as of Mar 25, the value is 8.51. This value is within the healthy range. It has increased from 5.53 (Mar 24) to 8.51, marking an increase of 2.98.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 329.96. It has increased from 326.43 (Mar 24) to 329.96, marking an increase of 3.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 329.96. It has increased from 326.43 (Mar 24) to 329.96, marking an increase of 3.53.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.96. It has decreased from 6.17 (Mar 24) to 0.96, marking a decrease of 5.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.61. This value is within the healthy range. It has decreased from 4.92 (Mar 24) to 3.61, marking a decrease of 1.31.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.59. This value is within the healthy range. It has decreased from 4.89 (Mar 24) to 3.59, marking a decrease of 1.30.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.43. This value is within the healthy range. It has increased from 6.57 (Mar 24) to 11.43, marking an increase of 4.86.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.49. This value is within the healthy range. It has increased from 5.50 (Mar 24) to 8.49, marking an increase of 2.99.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 237.80. This value is within the healthy range. It has decreased from 245.37 (Mar 24) to 237.80, marking a decrease of 7.57.
- For PBDIT Margin (%), as of Mar 25, the value is 374.74. This value is within the healthy range. It has increased from 79.63 (Mar 24) to 374.74, marking an increase of 295.11.
- For PBIT Margin (%), as of Mar 25, the value is 372.06. This value exceeds the healthy maximum of 20. It has increased from 79.17 (Mar 24) to 372.06, marking an increase of 292.89.
- For PBT Margin (%), as of Mar 25, the value is 1,185.26. This value is within the healthy range. It has increased from 106.48 (Mar 24) to 1,185.26, marking an increase of 1,078.78.
- For Net Profit Margin (%), as of Mar 25, the value is 880.65. This value exceeds the healthy maximum of 10. It has increased from 89.09 (Mar 24) to 880.65, marking an increase of 791.56.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 24,669.02. This value exceeds the healthy maximum of 20. It has increased from 3,975.34 (Mar 24) to 24,669.02, marking an increase of 20,693.68.
- For Return on Networth / Equity (%), as of Mar 25, the value is 72.06. This value is within the healthy range. It has decreased from 75.16 (Mar 24) to 72.06, marking a decrease of 3.10.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 10. It has decreased from 1.49 (Mar 24) to 1.08, marking a decrease of 0.41.
- For Return On Assets (%), as of Mar 25, the value is 61.81. This value is within the healthy range. It has decreased from 63.13 (Mar 24) to 61.81, marking a decrease of 1.32.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1.5. It has increased from 0.19 (Mar 24) to 0.27, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.19 (Mar 24) to 0.27, marking an increase of 0.08.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 25,499.50. This value is within the healthy range. It has increased from 475.29 (Mar 24) to 25,499.50, marking an increase of 25,024.21.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4,589.50. This value is within the healthy range. It has increased from 368.69 (Mar 24) to 4,589.50, marking an increase of 4,220.81.
- For Enterprise Value (Cr.), as of Mar 25, the value is 143.62. It has decreased from 185.77 (Mar 24) to 143.62, marking a decrease of 42.15.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 105.53. This value exceeds the healthy maximum of 3. It has increased from 21.32 (Mar 24) to 105.53, marking an increase of 84.21.
- For EV / EBITDA (X), as of Mar 25, the value is 28.16. This value exceeds the healthy maximum of 15. It has increased from 26.77 (Mar 24) to 28.16, marking an increase of 1.39.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 107.89. This value exceeds the healthy maximum of 3. It has increased from 21.39 (Mar 24) to 107.89, marking an increase of 86.50.
- For Price / BV (X), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 1. It has decreased from 0.40 (Mar 24) to 0.31, marking a decrease of 0.09.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 108.00. This value exceeds the healthy maximum of 3. It has increased from 21.39 (Mar 24) to 108.00, marking an increase of 86.61.
- For EarningsYield, as of Mar 25, the value is 2.29. This value is below the healthy minimum of 5. It has increased from 1.86 (Mar 24) to 2.29, marking an increase of 0.43.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Maha Rashtra Apex Corporation Ltd:
- Net Profit Margin: 880.65%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.08% (Industry Average ROCE: 21.7%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 72.06% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4589.5
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 80.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 880.65%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 3rd Floor, Front Wing, North Block, Bengaluru Karnataka 560042 | mracl.ho@manipal.com http://www.maharashtraapex.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. K B Shetty | Chairman |
| Mr. Aspi Nariman Katgara | Managing Director |
| Mrs. V B Jyothi | Director |
| Mr. Nagarajan Sivarmakrishnan | Director |
| Mr. Yazdin Jimmy Mistry | Director |
| Mrs. Vidya Mananjay More | Director |
FAQ
What is the intrinsic value of Maha Rashtra Apex Corporation Ltd?
Maha Rashtra Apex Corporation Ltd's intrinsic value (as of 11 December 2025) is 2832.34 which is 3681.50% higher the current market price of 74.90, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 103 Cr. market cap, FY2025-2026 high/low of 190/69.0, reserves of ₹445.09 Cr, and liabilities of 536.20 Cr.
What is the Market Cap of Maha Rashtra Apex Corporation Ltd?
The Market Cap of Maha Rashtra Apex Corporation Ltd is 103 Cr..
What is the current Stock Price of Maha Rashtra Apex Corporation Ltd as on 11 December 2025?
The current stock price of Maha Rashtra Apex Corporation Ltd as on 11 December 2025 is 74.9.
What is the High / Low of Maha Rashtra Apex Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Maha Rashtra Apex Corporation Ltd stocks is 190/69.0.
What is the Stock P/E of Maha Rashtra Apex Corporation Ltd?
The Stock P/E of Maha Rashtra Apex Corporation Ltd is .
What is the Book Value of Maha Rashtra Apex Corporation Ltd?
The Book Value of Maha Rashtra Apex Corporation Ltd is 325.
What is the Dividend Yield of Maha Rashtra Apex Corporation Ltd?
The Dividend Yield of Maha Rashtra Apex Corporation Ltd is 0.00 %.
What is the ROCE of Maha Rashtra Apex Corporation Ltd?
The ROCE of Maha Rashtra Apex Corporation Ltd is 72.0 %.
What is the ROE of Maha Rashtra Apex Corporation Ltd?
The ROE of Maha Rashtra Apex Corporation Ltd is 71.2 %.
What is the Face Value of Maha Rashtra Apex Corporation Ltd?
The Face Value of Maha Rashtra Apex Corporation Ltd is 10.0.